Cargando…
Is Canada missing out? An assessment of drugs approved internationally between 2016 and 2020 and not submitted for Health Canada review
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
CMA Impact Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260241/ https://www.ncbi.nlm.nih.gov/pubmed/37308215 http://dx.doi.org/10.1503/cmaj.230339 |
| _version_ | 1785057821353574400 |
|---|---|
| author | Gaudette, Étienne Rizzardo, Shirin Wladyka, Sasha B. Rahman, Tuhin Pothier, Kevin R. |
| author_facet | Gaudette, Étienne Rizzardo, Shirin Wladyka, Sasha B. Rahman, Tuhin Pothier, Kevin R. |
| author_sort | Gaudette, Étienne |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10260241 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | CMA Impact Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102602412023-06-13 Is Canada missing out? An assessment of drugs approved internationally between 2016 and 2020 and not submitted for Health Canada review Gaudette, Étienne Rizzardo, Shirin Wladyka, Sasha B. Rahman, Tuhin Pothier, Kevin R. CMAJ Analysis CMA Impact Inc. 2023-06-12 2023-06-12 /pmc/articles/PMC10260241/ /pubmed/37308215 http://dx.doi.org/10.1503/cmaj.230339 Text en © 2023 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| spellingShingle | Analysis Gaudette, Étienne Rizzardo, Shirin Wladyka, Sasha B. Rahman, Tuhin Pothier, Kevin R. Is Canada missing out? An assessment of drugs approved internationally between 2016 and 2020 and not submitted for Health Canada review |
| title | Is Canada missing out? An assessment of drugs approved internationally between 2016 and 2020 and not submitted for Health Canada review |
| title_full | Is Canada missing out? An assessment of drugs approved internationally between 2016 and 2020 and not submitted for Health Canada review |
| title_fullStr | Is Canada missing out? An assessment of drugs approved internationally between 2016 and 2020 and not submitted for Health Canada review |
| title_full_unstemmed | Is Canada missing out? An assessment of drugs approved internationally between 2016 and 2020 and not submitted for Health Canada review |
| title_short | Is Canada missing out? An assessment of drugs approved internationally between 2016 and 2020 and not submitted for Health Canada review |
| title_sort | is canada missing out? an assessment of drugs approved internationally between 2016 and 2020 and not submitted for health canada review |
| topic | Analysis |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260241/ https://www.ncbi.nlm.nih.gov/pubmed/37308215 http://dx.doi.org/10.1503/cmaj.230339 |
| work_keys_str_mv | AT gaudetteetienne iscanadamissingoutanassessmentofdrugsapprovedinternationallybetween2016and2020andnotsubmittedforhealthcanadareview AT rizzardoshirin iscanadamissingoutanassessmentofdrugsapprovedinternationallybetween2016and2020andnotsubmittedforhealthcanadareview AT wladykasashab iscanadamissingoutanassessmentofdrugsapprovedinternationallybetween2016and2020andnotsubmittedforhealthcanadareview AT rahmantuhin iscanadamissingoutanassessmentofdrugsapprovedinternationallybetween2016and2020andnotsubmittedforhealthcanadareview AT pothierkevinr iscanadamissingoutanassessmentofdrugsapprovedinternationallybetween2016and2020andnotsubmittedforhealthcanadareview |